Association of the Geriatric Nutritional Risk Index with the survival of patients with non-small-cell lung cancer after platinum-based chemotherapy

被引：0
|
作者：
Masato Karayama
Yusuke Inoue
Hideki Yasui
Hironao Hozumi
Yuzo Suzuki
Kazuki Furuhashi
Tomoyuki Fujisawa
Noriyuki Enomoto
Yutaro Nakamura
Naoki Inui
Takafumi Suda
机构：
[1] Hamamatsu University School of Medicine,Department of Chemotherapy
[2] Hamamatsu University School of Medicine,Second Division, Department of Internal Medicine
[3] Hamamatsu University School of Medicine,Department of Clinical Pharmacology and Therapeutics
来源：
BMC Pulmonary Medicine | / 21卷
关键词：
Albumin; Cachexia; Hypoalbuminemia; Malnutrition; Nutrition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Association of POLK Polymorphisms with Platinum-Based Chemotherapy Response and Severe Toxicity in Non-small Cell Lung Cancer Patients
    Minhua Shao
    Bo Jin
    Yanjie Niu
    Junyi Ye
    Daru Lu
    Baohui Han
    Cell Biochemistry and Biophysics, 2014, 70 : 1227 - 1237
  • [42] Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer
    Liu, Stephen V.
    Camidge, D. Ross
    Gettinger, Scott N.
    Giaccone, Giuseppe
    Heist, Rebecca S.
    Hodi, F. Stephen
    Ready, Neal E.
    Zhang, Wei
    Wallin, Jeffrey
    Funke, Roel
    Waterkamp, Daniel
    Foster, Paul
    Iizuka, Koho
    Powderly, John
    EUROPEAN JOURNAL OF CANCER, 2018, 101 : 114 - 122
  • [43] DNA Repair Capacity in Peripheral Lymphocytes Predicts Survival of Patients With Non-Small-Cell Lung Cancer Treated With First-Line Platinum-Based Chemotherapy
    Wang, Li-E
    Yin, Ming
    Dong, Qiong
    Stewart, David J.
    Merriman, Kelly W.
    Amos, Christopher I.
    Spitz, Margaret R.
    Wei, Qingyi
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (31) : 4121 - 4128
  • [44] Association of POLK Polymorphisms with Platinum-Based Chemotherapy Response and Severe Toxicity in Non-small Cell Lung Cancer Patients
    Shao, Minhua
    Jin, Bo
    Niu, Yanjie
    Ye, Junyi
    Lu, Daru
    Han, Baohui
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2014, 70 (02) : 1227 - 1237
  • [45] Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: A meta-analysis of the published literature
    D'Addario, G
    Pintilie, M
    Leighl, NB
    Feld, R
    Cerny, T
    Shepherd, FA
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2926 - 2936
  • [46] Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer
    He, Caiyun
    Duan, Zhipeng
    Li, Ping
    Xu, Qian
    Yuan, Yuan
    ANTI-CANCER DRUGS, 2013, 24 (03) : 300 - 305
  • [47] Association of Bcl2 family gene polymorphisms with response to and toxicity of platinum-based chemotherapy in non-small-cell lung cancer patients in a Chinese population
    Qian, Ji
    Wu, Qi Han
    Lu, Da Ru
    Wei, Qing Yi
    CANCER RESEARCH, 2011, 71
  • [48] Outcomes of concurrent radiotherapy with weekly docetaxel and platinum-based chemotherapy in stage III non-small-cell lung cancer
    Kaderbhai, C-G
    Coudert, B.
    Bertaut, A.
    Adnet, J.
    Favier, L.
    Lagrange, A.
    Peignaux-Casasnovas, K.
    Mettey, L.
    Tharin, Z.
    Foucher, P.
    Martin, E.
    CANCER RADIOTHERAPIE, 2020, 24 (04): : 279 - 287
  • [49] Tirapazamine: A new drug producing tumor specific enhancement of platinum-based chemotherapy in non-small-cell lung cancer
    Wouters, BG
    Wang, LH
    Brown, JM
    ANNALS OF ONCOLOGY, 1999, 10 : 29 - 33
  • [50] Role of BCL2-associated athanogene in resistance to platinum-based chemotherapy in non-small-cell lung cancer
    Wang, Yadi
    Ha, Minwen
    Liu, Jingsong
    Li, Ping
    Zhang, Wenlu
    Zhang, Xuan
    ONCOLOGY LETTERS, 2016, 11 (02) : 984 - 990
12345